This inventor holds 2 USPTO granted patents. Top assignee: Academia Sinica. Active years: 2009-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Taichung County, TW (2009)
- Taipei, TW (2010)
Company Filing History:
Years Active: 2009-2010
Title: Yi-Wen Lin: Innovator in Insulin Resistance Treatment
Introduction
Yi-Wen Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in the treatment of insulin resistance. With a total of 2 patents, Lin's work is paving the way for new therapeutic approaches.
Latest Patents
Lin's latest patents focus on innovative methods for treating insulin resistance. One of his notable patents is titled "Treatment of insulin resistance by administering an acid-sensing ion channel 3 inhibitor." This patent discloses a method for treating insulin resistance and identifies a compound that can be used for this purpose. Another patent, simply titled "Treatment of insulin resistance," also outlines methods for addressing this critical health issue.
Career Highlights
Yi-Wen Lin is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to collaborate with other leading researchers in the field, enhancing the impact of his inventions.
Collaborations
Lin has worked alongside notable colleagues, including Chih-Cheng Chen and Shyh-Jer Huang. Their collaborative efforts contribute to the advancement of research in insulin resistance and related areas.
Conclusion
Yi-Wen Lin's innovative work in the treatment of insulin resistance showcases his dedication to improving health outcomes. His patents reflect a commitment to scientific advancement and collaboration in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile